Rare non surgically correctable form of primary aldosteronism

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

1 event
Jul 1993

Orlaam: FDA approved

For the management of opiate dependence.

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

1

Copay cards

Copay Assistance1

Orlaam

Biodevelopment Corporation

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Orlaam

(Levomethadyl acetate hydrochloride)Orphan drug

Biodevelopment Corporation

Approved Jul 1993

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Rare non surgically correctable form of primary aldosteronism.
Search all trials →
Search clinical trials for Rare non surgically correctable form of primary aldosteronism

Recent News & Research

No recent news articles indexed yet for Rare non surgically correctable form of primary aldosteronism.
Search PubMed for Rare non surgically correctable form of primary aldosteronism

Browse all Rare non surgically correctable form of primary aldosteronism news →

Specialist Network

No specialists currently listed for Rare non surgically correctable form of primary aldosteronism.

View all Rare non surgically correctable form of primary aldosteronism specialists →

Quick Actions